Skip to main content
SpringerLink
Log in

Rituximab treatment for refractory steroid-resistant nephrotic syndrome

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Counsilman CE, Jol-van der Zijde CM, Stevens J, Cransberg K, Bredius RG, Sukhai RN (2015) Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome. Pediatr Nephrol 30:1367–1370

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S (2014) Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol 29:1181–1187

    Article  PubMed  Google Scholar 

  3. Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S (2010) Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatr Nephrol 25:957–959

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Shuichi Ito and Dr. Masaki Takahashi for their contributions to this study. We would also like to thank Dr. Julian Tang from the Department of Education for Clinical Research, National Center for Child Health and Development, for proofreading and editing the manuscript.

Conflict of interest

Koichi Kamei has received lecture fees from Chugai Seiyaku. Kenji Ishikura has received lecture fees from Novartis Pharma, Asahi Kasei Pharma, and Zenyaku Kogyo.

Author information

Authors and Affiliations

  1. Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan

    Koichi Kamei & Kenji Ishikura

Authors
  1. Koichi Kamei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenji Ishikura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koichi Kamei.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamei, K., Ishikura, K. Rituximab treatment for refractory steroid-resistant nephrotic syndrome. Pediatr Nephrol 31, 337–338 (2016). https://doi.org/10.1007/s00467-015-3205-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-015-3205-4

Keywords

Search

Navigation